EUVIMEDEUVIMED entdecken
Crossref

Cenobamate and Trazodone Combination Suppresses Seizures, EEG Alterations, Preserves Neuronal Architecture and Normalizes the BDNF/TrkB Expression in PTZ‑Kindled Mice

Waleed Shakeel, Khaled Ahmed Saghir, Waseem Ashraf iD, Saleh A Alqarni, Syed Muhammad Muneeb Anjum, Fakhir Hannan, Faleh Alqahtani, Imran Imran

Neurochemical Research · 2026

DOI: 10.1007/s11064-026-04859-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2026. Verfasst von Waleed Shakeel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, 60800, Pakistan. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Receptor, trkB, Seizures, Anticonvulsants. Die Arbeit nennt 64 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polytherapy is increasingly needed to overcome the limitations of monotherapy in epilepsy and its comorbidities. Therefore, we investigated the effect of cenobamate (CNB, 30 mg/kg) and trazodone (TZ, 10 mg/kg), alone and in combination, in PTZ-kindling model, where mice received 11 doses of pentylenetetrazole (PTZ, 40 mg/kg) every other day for three weeks. Behavioral seizure scoring, electroencephalographic (EEG) changes at the 1st, 5th, and 11th injections, molecular markers, and hippocampal histopathology were assessed. TZ + CNB suppressed seizure progression with no tonic-clonic seizures observed throughout kindling period (p < 0.0001), whereas monotherapy by these drugs showed no significant suppression. PTZ produced the most pronounced EEG abnormalities, which CNB and TZ alone did not differ significantly. Combination therapy revealed the greatest reductions across all EEG parameters (q = 0.0004-0.0014), approaching near-baseline values by the 11th injection. Furthermore, brain homogenates were assessed for BDNF, GFAP, and TrkB expression levels by RT-PCR. CNB showed mixed effects (p = 0.0081-0.0631), while TZ (p = 0.0971-0.1422) produced no significant difference from PTZ40. TZ + CNB shifted these markers toward normal levels (p = 0.0001-0.0054), outperforming monotherapies. Hippocampal Nissl-stained sections showed neurodegenerative damage with monotherapies across all regions, while TZ + CNB exhibited substantial preservation, with minimal alteration in hippocampal and cortical architecture. These parallel findings suggest that positive allosteric GABAA modulation and persistent sodium-current inhibition by CNB, combined with TZ serotonergic modulation, reduce hyperexcitability, pathological neuroplasticity, and glial reactivity. Collectively, TZ + CNB is a promising mechanistically complementary regimen that suppresses seizure progression and associated molecular and neurostructural pathology, which needs further preclinical optimization and translational investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorReceptor, trkBSeizuresAnticonvulsantsTrazodoneNeuronsCarbamatesKindling, NeurologicCarbazolesAnimalsMaleMiceElectroencephalographyPentylenetetrazoleDrug Therapy, CombinationHippocampusMembrane GlycoproteinsChlorophenolsTetrazoles

Stichwörter der Autor:innen

BDNF/TrkBCenobamateEEGNissl stainingPTZ-kindlingTrazodone

Substanzen

Brain-Derived Neurotrophic FactorReceptor, trkBAnticonvulsantsPentylenetetrazoleTrazodoneCenobamateCarbamatesBdnf protein, mouseCarbazolesNtrk2 protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, 60800, Pakistan.
  • Faculty of Pharmacy, University of Chakwal, Chakwal, 48800, Pakistan.
  • Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, 60800, Pakistan. waseem.ashraf@bzu.edu.pk.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
  • The Institute of Pharmaceutical Sciences, University of Veterinary & Animal Sciences, Lahore, 75270, Pakistan.
  • College of Agriculture and Biotechnology, Zhejiang University, Hangzhou, 310058, China.

ORCID-Profile: Waseem Ashraf

Förderung

  • King Saud University

Zitieren

APA

Shakeel, W., Saghir, K. A., Ashraf, W., Alqarni, S. A., Anjum, S. M. M., Hannan, F., Alqahtani, F., & Imran, I. (2026). Cenobamate and Trazodone Combination Suppresses Seizures, EEG Alterations, Preserves Neuronal Architecture and Normalizes the BDNF/TrkB Expression in PTZ‑Kindled Mice. Neurochemical Research. https://doi.org/10.1007/s11064-026-04859-8

Vancouver

Shakeel W, Saghir KA, Ashraf W, Alqarni SA, Anjum SMM, Hannan F, et al. Cenobamate and Trazodone Combination Suppresses Seizures, EEG Alterations, Preserves Neuronal Architecture and Normalizes the BDNF/TrkB Expression in PTZ‑Kindled Mice. Neurochemical Research. 2026. doi:10.1007/s11064-026-04859-8

BibTeX
@article{Shakeel2026,
  author = {Shakeel, Waleed and Saghir, Khaled Ahmed and Ashraf, Waseem and Alqarni, Saleh A and Anjum, Syed Muhammad Muneeb and Hannan, Fakhir and Alqahtani, Faleh and Imran, Imran},
  title = {Cenobamate and Trazodone Combination Suppresses Seizures, EEG Alterations, Preserves Neuronal Architecture and Normalizes the BDNF/TrkB Expression in PTZ‑Kindled Mice},
  journal = {Neurochemical Research},
  year = {2026},
  doi = {10.1007/s11064-026-04859-8}
}
Kostenlos starten →